7Baggers

Global Medical REIT Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 01.032.063.094.125.156.187.21Milllion

Global Medical REIT Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 
                                        
  assets                                      
  investment in real estate:                                      
  land173,123,000 173,293,000 174,300,000 168,110,000 162,391,000 164,315,000 164,315,000 164,315,000 165,242,000 167,285,000 168,308,000 168,289,000 165,045,000 155,529,000 152,060,000 149,249,000 145,424,000 133,040,000 128,857,000 116,123,000 104,316,000 101,715,000 95,381,000 86,878,000 76,831,000 68,326,000 63,710,000 56,839,000 55,330,000 52,301,000 42,701,000 36,839,127 25,822,453 23,130,337 17,785,001 11,733,852 7,043,852 7,043,852 
  building1,095,324,000 1,064,782,000 1,044,019,000 1,041,006,000 1,028,539,000 1,036,224,000 1,035,705,000 1,034,822,000 1,038,464,000 1,077,340,000 1,079,781,000 1,079,380,000 1,049,876,000 1,002,087,000 985,091,000 964,169,000 931,510,000 883,901,000 851,427,000 793,559,000 755,807,000 745,649,000 693,533,000 637,505,000 597,029,000 533,430,000 518,451,000 493,503,000 486,766,000 436,185,000 384,338,000 349,041,480 306,198,609 270,401,823 179,253,398    
  site improvements24,966,000 24,266,000 23,973,000 22,946,000 21,960,000 21,984,000 21,974,000 21,480,000 21,404,000 22,024,000 22,024,000 21,983,000 20,805,000 19,596,000 19,021,000 18,017,000 17,011,000 15,669,000 15,183,000 13,268,000 11,593,000 11,303,000 9,912,000 9,100,000 7,672,000 6,982,000 6,880,000 6,714,000 6,562,000 5,590,000 4,808,000 3,992,974 3,115,289 2,686,216 1,465,273    
  tenant improvements80,019,000 75,023,000 69,679,000 66,933,000 66,004,000 67,021,000 66,358,000 65,772,000 66,544,000 66,375,000 65,987,000 65,004,000 62,500,000 60,154,000 58,900,000 56,156,000 53,730,000 50,596,000 49,204,000 46,965,000 41,891,000 37,044,000 33,909,000 31,465,000 27,371,000 16,206,000 15,357,000 14,328,000 12,189,000 9,201,000 8,010,000 5,095,651 2,996,662 2,552,449 1,186,014    
  acquired lease intangible assets147,376,000 141,828,000 138,945,000 137,886,000 136,394,000 138,617,000 138,617,000 138,617,000 139,715,000 148,249,000 148,077,000 147,836,000 146,339,000 130,790,000 127,931,000 123,918,000 112,649,000 103,269,000 98,234,000 91,465,000 83,269,000 78,977,000 72,794,000 65,498,000 54,698,000 43,987,000 43,152,000 41,653,000 41,162,000 34,034,000 31,650,000 27,308,632 17,218,214 15,991,981 7,144,276    
  ​1,520,808,000 1,479,192,000 1,450,916,000 1,436,881,000 1,415,288,000 1,428,161,000 1,426,969,000 1,425,006,000 1,431,369,000 1,481,273,000 1,484,177,000 1,482,492,000 1,444,565,000 1,368,156,000 1,343,003,000 1,311,509,000 1,260,324,000 1,186,475,000 1,142,905,000 1,061,380,000 996,876,000                  
  less: accumulated depreciation and amortization-316,649,000 -301,190,000 -288,921,000 -283,941,000 -271,764,000 -262,287,000 -247,503,000 -232,518,000 -218,109,000 -213,690,000 -198,218,000 -182,255,000 -172,006,000 -157,132,000 -143,255,000 -130,284,000 -117,720,000 -105,779,000 -94,462,000 -83,893,000 -73,979,000 -64,635,000 -56,503,000 -48,731,000 -41,882,000 -35,771,000 -30,625,000 -26,839,000 -22,026,000 -17,420,000 -13,594,000 -10,142,823       
  investment in real estate1,204,159,000 1,178,002,000 1,161,995,000 1,152,940,000 1,143,524,000 1,165,874,000 1,179,466,000 1,192,488,000 1,213,260,000 1,267,583,000 1,285,959,000 1,300,237,000 1,272,559,000 1,211,024,000 1,199,748,000 1,181,225,000 1,142,604,000 1,080,696,000 1,048,443,000 977,487,000 922,897,000 910,053,000 849,026,000 781,715,000 721,719,000 633,160,000 616,925,000 586,198,000 579,983,000 519,891,000 457,913,000 412,135,041 331,612,458 294,100,857 196,365,771 122,311,086 92,152,179 92,696,181 
  cash and cash equivalents6,580,000 5,412,000 6,815,000 5,723,000 4,978,000 1,333,000 1,278,000 1,281,000 2,460,000 4,603,000 4,016,000 3,199,000 5,873,000 1,854,000 7,213,000 6,030,000 5,821,000 5,304,000 5,507,000 2,052,000 8,392,000 11,340,000 2,765,000 2,815,000 3,216,000 1,844,000 3,631,000 3,005,000 4,755,000 3,351,000 5,109,000        
  restricted cash2,646,000 2,176,000 2,127,000 2,066,000 2,840,000 6,473,000 5,446,000 6,331,000 7,325,000 9,378,000 10,439,000 10,396,000 8,327,000 6,336,000 5,546,000 5,839,000 6,549,000 6,096,000 5,246,000 5,210,000 4,945,000 5,536,000 4,420,000 3,011,000 2,656,000 1,464,000 1,212,000 817,000 1,432,000 4,050,000 2,005,000 2,040,026 2,291,080 1,773,909 941,344 805,776 977,578 1,277,831 
  tenant receivables7,826,000 8,104,000 7,424,000 8,122,000 8,073,000 7,743,000 6,762,000 7,527,000 7,381,000 7,402,000 8,040,000 6,382,000 6,189,000 6,477,000 6,070,000 5,126,000 4,886,000 5,585,000 5,596,000 6,702,000 5,888,000 5,708,000 4,957,000 4,167,000 3,935,000 3,559,000 2,905,000 1,744,000 1,339,000 1,253,000 704,000 616,741 534,484 347,110 212,435 177,369  261,955 
  due from related parties461,000 420,000 270,000 404,000 410,000 363,000 193,000 289,000 391,000 321,000 200,000 337,000 337,000 451,000 163,000 275,000 265,000 229,000 103,000 121,000 124,000 70,000 50,000 75,000               
  escrow deposits556,000 915,000 711,000 1,694,000 925,000 737,000 673,000 9,861,000 9,725,000 8,625,000 7,833,000 7,660,000 7,708,000 7,697,000 5,957,000 5,970,000 5,531,000 5,163,000 4,817,000 3,792,000 3,301,000 3,589,000 3,417,000 2,865,000 3,518,000 3,296,000 1,752,000 2,628,000 2,080,000 2,508,000 1,638,000 1,297,665 979,709 2,528,996 1,212,177 903,636 945,162 889,519 
  deferred assets28,672,000 28,251,000 28,208,000 27,685,000 28,360,000 27,995,000 27,132,000 26,748,000 26,189,000 30,322,000 29,616,000 28,667,000 27,731,000 26,714,000 25,417,000 24,422,000 23,050,000 21,676,000 20,272,000 18,928,000 17,433,000 16,141,000 14,512,000 13,307,000 11,831,000 10,358,000 9,352,000 8,590,000 7,200,000 5,171,000 3,993,000 2,923,494 1,867,010 1,087,148 704,537 245,619 1,735,973 436,068 
  derivative asset10,396,000 13,713,000 18,613,000 14,967,000 27,672,000 29,285,000 25,125,000 38,379,000 35,864,000 27,428,000 34,705,000 36,926,000 16,583,000 12,692,000 1,236,000 219,000 137,000 136,000     2,194,000                
  goodwill5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000 5,903,000                   
  investment in unconsolidated joint venture1,917,000 1,992,000 2,066,000                                    
  other assets27,843,000 24,667,000 22,354,000 23,091,000 18,530,000 17,874,000 15,722,000 13,713,000 12,302,000 7,473,000 6,550,000 7,042,000 6,056,000 6,345,000 6,232,000 8,297,000 5,219,000 5,530,000 5,019,000 5,356,000 3,587,000 3,731,000 3,593,000 4,363,000 3,847,000 3,009,000 322,000 1,109,000 2,283,000 527,000 459,000 160,214 88,695 11,484 140,374    
  total assets1,296,959,000 1,269,555,000 1,256,486,000 1,242,595,000 1,241,215,000 1,263,580,000 1,267,700,000 1,302,520,000 1,320,800,000 1,369,038,000 1,393,261,000 1,406,749,000 1,357,266,000 1,285,493,000 1,263,485,000 1,243,306,000 1,199,965,000 1,136,318,000 1,100,906,000 1,025,551,000 966,567,000 956,168,000 884,934,000 812,318,000 750,722,000 656,690,000 636,099,000 604,091,000 602,027,000 539,856,000 474,571,000 428,927,663 369,395,591 325,768,465 227,319,130 205,791,478 98,385,696 96,096,760 
  liabilities and equity                                      
  liabilities:                                      
  credit facility, net of unamortized debt issuance costs of 3,768 and 4,868 at june 30, 2025 and december 31, 2024, respectively698,832,000                                      
  notes payable, net of unamortized debt issuance costs of 4 and 22 at june 30, 2025 and december 31, 2024, respectively14,153,000                                      
  accounts payable and accrued expenses19,006,000 14,519,000 16,468,000 13,350,000 11,962,000 10,520,000 12,781,000 13,300,000 15,457,000 12,604,000 13,819,000 13,100,000 11,922,000 9,272,000 10,344,000 11,065,000 8,080,000 7,230,000 7,279,000 8,329,000 8,836,000 7,144,000 5,069,000 5,501,000 4,224,000 3,385,000 3,664,000 4,420,000 5,494,000 4,125,000 2,020,000 2,433,549 2,216,953 1,932,590 573,997    
  dividends payable11,985,000 16,597,000 16,520,000 16,534,000 16,280,000 16,157,000 16,134,000 16,055,000 16,048,000 15,854,000 15,821,000 15,777,000 15,926,000 15,823,000 15,668,000 15,309,000 15,251,000 14,482,000 12,470,000 11,843,000 11,281,000 10,949,000 11,091,000 9,470,000 9,081,000 8,985,000 6,981,000 6,109,000 5,940,000 5,826,000 5,638,000 4,767,037 3,700,936 3,651,817 3,604,037 3,592,786   
  security deposits3,407,000 3,374,000 3,324,000 3,222,000 3,973,000 4,376,000 3,688,000 3,913,000 4,213,000 4,688,000 5,461,000 5,404,000 5,304,000 4,616,000 4,540,000 4,600,000 4,385,000 4,367,000                2,099,844 719,592 597,593 319,499 319,499 
  other liabilities18,438,000 16,030,000 14,191,000 12,370,000 12,809,000 12,952,000 12,770,000 12,138,000 12,137,000 8,226,000 7,363,000 6,848,000 7,428,000 7,090,000 7,709,000 7,104,000 5,983,000 6,793,000 6,171,000                    
  acquired lease intangible liability6,117,000 3,902,000 3,936,000 3,638,000 4,149,000 4,713,000 5,281,000 5,860,000 6,444,000 7,028,000 7,613,000 8,220,000 7,903,000 8,161,000 8,128,000 8,333,000 8,437,000 7,998,000 8,222,000 8,621,000 5,598,000 3,425,000 3,164,000 3,287,000 2,778,000 2,004,000 2,028,000 2,034,000 2,081,000 1,488,000 1,291,000 1,080,123 1,112,566 475,343 277,917    
  total liabilities771,938,000 731,452,000 700,570,000 677,989,000 662,843,000 666,482,000 661,886,000 668,872,000 679,408,000 740,563,000 744,196,000 742,165,000 708,157,000 632,876,000 625,908,000 613,081,000 562,710,000 540,499,000 643,146,000 576,344,000 523,858,000 517,378,000 424,581,000 440,875,000 389,119,000 286,128,000 336,349,000 349,435,000 346,514,000 285,113,000 215,558,000 175,900,856 193,092,997 176,513,596 72,290,752 46,083,186 86,250,769 83,346,083 
  commitments and contingencies                                      
  equity:                                      
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2025 and december 31, 2024, respectively74,959,000                                      
  common stock67,000 67,000 67,000 67,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 66,000 65,000 65,000 64,000 64,000 61,000 49,000 48,000 46,000 44,000 44,000 36,000 35,000 35,000 26,000 22,000 22,000 22,000 22,000 21,631       
  additional paid-in capital734,290,000 734,290,000 734,223,000 733,626,000 722,627,000 722,623,000 722,418,000 722,418,000 722,418,000 722,113,000 721,991,000 722,074,000 722,074,000 720,306,000 711,414,000 700,206,000 700,038,000 648,949,000 504,789,000 487,114,000 462,607,000 440,220,000 433,330,000 340,435,000 322,872,000 322,359,000 243,038,000 208,938,000 205,788,000 205,788,000 205,788,000 207,268,720 202,513,240 172,417,006 171,997,396 171,143,411 18,010,613 18,010,613 
  accumulated deficit-316,510,000 -305,677,000 -293,736,000 -281,067,000 -268,885,000 -251,963,000 -238,984,000 -224,375,000 -213,744,000 -211,794,000 -198,706,000 -185,316,000 -179,614,000 -168,089,000 -157,017,000 -147,562,000 -138,088,000 -127,480,000 -116,773,000 -107,943,000 -88,037,000 -78,990,000 -71,389,000 -63,846,000 -57,397,000 -51,390,000 -45,007,000 -46,855,000 -42,739,000 -38,349,000 -34,434,000 -29,914,472 -26,231,752 -23,179,743 -16,986,624 -11,452,725 -5,877,113 -5,261,363 
  accumulated other comprehensive income10,396,000 13,713,000 18,613,000 14,967,000 27,672,000 29,285,000 25,125,000 38,379,000 35,859,000 27,410,000 34,674,000 36,883,000 16,527,000 10,757,000                         
  total global medical reit inc. stockholders' equity503,202,000 517,352,000 534,126,000 542,552,000 556,439,000 574,970,000 583,584,000 611,447,000 619,558,000 612,754,000 632,984,000 648,666,000 634,012,000 637,998,000 622,785,000 615,721,000 623,189,000 581,901,000 444,805,000 434,527,000  415,601,000 430,270,000 340,988,000 331,176,000  269,295,000 236,955,000 238,030,000 242,420,000 246,335,000 252,334,882       
  noncontrolling interest21,819,000 20,751,000 21,790,000 22,054,000 21,933,000 22,128,000 22,230,000 22,201,000 21,834,000 15,721,000 16,081,000 15,918,000 15,097,000 14,619,000 14,792,000 14,504,000 14,066,000 13,918,000 12,955,000 14,680,000 14,788,000 23,189,000 30,083,000 30,455,000 30,427,000 30,342,000 30,455,000 17,701,000 17,483,000 12,323,000 12,678,000 691,925       
  total equity525,021,000 538,103,000 555,916,000 564,606,000 578,372,000 597,098,000 605,814,000 633,648,000 641,392,000 628,475,000 649,065,000 664,584,000 649,109,000 652,617,000 637,577,000 630,225,000 637,255,000 595,819,000 457,760,000 449,207,000 442,709,000 438,790,000 460,353,000 371,443,000 361,603,000      259,013,000 253,026,807       
  total liabilities and equity1,296,959,000 1,269,555,000 1,256,486,000 1,242,595,000 1,241,215,000 1,263,580,000 1,267,700,000 1,302,520,000 1,320,800,000 1,369,038,000 1,393,261,000 1,406,749,000 1,357,266,000 1,285,493,000 1,263,485,000 1,243,306,000 1,199,965,000 1,136,318,000 1,100,906,000 1,025,551,000 966,567,000 956,168,000 884,934,000 812,318,000 750,722,000              
  credit facility, net of unamortized debt issuance costs of 4,318 and 4,868 at march 31, 2025 and december 31, 2024, respectively 662,782,000                                     
  notes payable, net of unamortized debt issuance costs of 13 and 22 at march 31, 2025 and december 31, 2024, respectively 14,248,000                                     
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2025 and december 31, 2024, respectively 74,959,000                                     
  credit facility, net of unamortized debt issuance costs of 4,868 and 7,067 at december 31, 2024 and december 31, 2023, respectively  631,732,000                                    
  notes payable, net of unamortized debt issuance costs of 22 and 66 at december 31, 2024 and december 31, 2023, respectively  14,399,000                                    
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2024 and december 31, 2023, respectively  74,959,000                                    
  credit facility, net of unamortized debt issuance costs of 5,418 and 7,067 at september 30, 2024 and december 31, 2023, respectively   614,382,000                                   
  notes payable, net of unamortized debt issuance costs of 31 and 66 at september 30, 2024 and december 31, 2023, respectively   14,493,000                                   
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2024 and december 31, 2023, respectively   74,959,000                                   
  credit facility, net of unamortized debt issuance costs of 5,968 and 7,067 at june 30, 2024 and december 31, 2023, respectively    599,032,000                                  
  notes payable, net of unamortized debt issuance costs of 40 and 66 at june 30, 2024 and december 31, 2023, respectively    14,638,000                                  
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2024 and december 31, 2023, respectively    74,959,000                                  
  credit facility, net of unamortized debt issuance costs of 6,518 and 7,067 at march 31, 2024 and december 31, 2023, respectively     592,082,000                                 
  notes payable, net of unamortized debt issuance costs of 53 and 66 at march 31, 2024 and december 31, 2023, respectively     25,682,000                                 
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2024 and december 31, 2023, respectively     74,959,000                                 
  credit facility, net of unamortized debt issuance costs of 7,067 and 9,253 at december 31, 2023 and december 31, 2022, respectively      585,333,000                                
  notes payable, net of unamortized debt issuance costs of 66 and 452 at december 31, 2023 and december 31, 2022, respectively      25,899,000                                
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2023 and december 31, 2022, respectively      74,959,000                                
  credit facility, net of unamortized debt issuance costs of 7,617 and 9,253 at september 30, 2023 and december 31, 2022, respectively       560,783,000                               
  notes payable, net of unamortized debt issuance costs of 337 and 452 at september 30, 2023 and december 31, 2022, respectively       56,823,000                               
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2023 and december 31, 2022, respectively       74,959,000                               
  credit facility, net of unamortized debt issuance costs of 8,155 and 9,253 at june 30, 2023 and december 31, 2022, respectively        567,988,000                              
  notes payable, net of unamortized debt issuance costs of 375 and 452 at june 30, 2023 and december 31, 2022, respectively        57,121,000                              
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2023 and december 31, 2022, respectively        74,959,000                              
  credit facility, net of unamortized debt issuance costs of 8,704 and 9,253 at march 31, 2023 and december 31, 2022, respectively         634,796,000                             
  notes payable, net of unamortized debt issuance costs of 413 and 452 at march 31, 2023 and december 31, 2022, respectively         57,367,000                             
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2023 and december 31, 2022, respectively         74,959,000                             
  credit facility, net of unamortized debt issuance costs of 9,253 and 8,033 at december 31, 2022 and december 31, 2021, respectively          636,447,000                            
  notes payable, net of unamortized debt issuance costs of 452 and 607 at december 31, 2022 and december 31, 2021, respectively          57,672,000                            
  derivative liability             1,865,000 7,790,000 12,070,000 13,814,000 14,603,000 18,086,000 19,505,000 21,495,000 20,461,000 8,685,000 10,399,000 9,083,000 5,520,000 3,487,000            
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2022 and december 31, 2021, respectively          74,959,000                            
  credit facility, net of unamortized debt issuance costs of 9,802 and 8,033 at september 30, 2022 and december 31, 2021, respectively           634,898,000                           
  notes payable, net of unamortized debt issuance costs of 491 and 607 at september 30, 2022 and december 31, 2021, respectively           57,918,000                           
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2022 and december 31, 2021, respectively           74,959,000                           
  credit facility, net of unamortized debt issuance costs of 7,113 and 8,033 at june 30, 2022 and december 31, 2021, respectively            602,987,000                          
  notes payable, net of unamortized debt issuance costs of 530 and 607 at june 30, 2022 and december 31, 2021, respectively            56,687,000                          
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2022 and december 31, 2021, respectively            74,959,000                          
  credit facility, net of unamortized debt issuance costs of 7,570 and 8,033 at march 31, 2022 and december 31, 2021, respectively             529,130,000                         
  notes payable, net of unamortized debt issuance costs of 568 and 607 at march 31, 2022 and december 31, 2021, respectively             56,919,000                         
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2022 and december 31, 2021, respectively             74,959,000                         
  credit facility, net of unamortized debt issuance costs of 8,033 and 3,559 at december 31, 2021 and december 31, 2020, respectively              514,567,000                        
  notes payable, net of unamortized debt issuance costs of 607 and 835 at december 31, 2021 and december 31, 2020, respectively              57,162,000                        
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2021 and december 31, 2020, respectively              74,959,000                        
  accumulated other comprehensive loss              -6,636,000 -11,946,000 -13,784,000 -14,588,000 -18,219,000 -19,651,000 -21,654,000 -20,632,000 -6,674,000 -10,596,000 -9,293,000 -5,743,000 -3,721,000 -109,000           
  credit facility, net of unamortized debt issuance costs of 8,497 and 3,559 at september 30, 2021 and december 31, 2020, respectively               497,203,000                       
  notes payable, net of unamortized debt issuance costs of 644 and 835 at september 30, 2021 and december 31, 2020, respectively               57,397,000                       
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2021 and december 31, 2020, respectively               74,959,000                       
  credit facility, net of unamortized debt issuance costs of 8,960 and 3,559 at june 30, 2021 and december 31, 2020, respectively                442,140,000                      
  notes payable, net of unamortized debt issuance costs of 706 and 835 at june 30, 2021 and december 31, 2020, respectively                64,620,000                      
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2021 and december 31, 2020, respectively                74,959,000                      
  credit facility, net of unamortized debt issuance costs of 3,284 and 3,559 at march 31, 2021 and december 31, 2020, respectively                 420,216,000                     
  notes payable, net of unamortized debt issuance costs of 772 and 835 at march 31, 2021 and december 31, 2020, respectively                 64,810,000                     
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2021 and december 31, 2020, respectively                 74,959,000                     
  credit facility, net of unamortized debt issuance costs of 3,559 and 3,832 at december 31, 2020 and december 31, 2019, respectively                  521,641,000                    
  notes payable, net of unamortized debt issuance costs of 835 and 667 at december 31, 2020 and december 31, 2019, respectively                  64,937,000                    
  security deposits and other                  4,340,000 5,571,000 5,814,000 6,546,000 6,351,000 6,362,000 5,881,000 4,122,000 4,152,000 3,928,000 5,052,000 4,912,000 2,128,000 2,206,145 2,444,842      
  due to related party                    1,957,000 1,948,000 1,648,000                
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2020 and december 31, 2019, respectively                  74,959,000                    
  credit facility, net of unamortized debt issuance costs of 3,875 and 3,832 at september 30, 2020 and december 31, 2019, respectively                   454,325,000                   
  notes payable, net of unamortized debt issuance costs of 898 and 667 at september 30, 2020 and december 31, 2019, respectively                   65,060,000                   
  other liability                   3,090,000 2,417,000 2,414,000 2,405,000 2,379,000 2,371,000 2,367,000             
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2020 and december 31, 2019, respectively                   74,959,000                   
  credit facility, net of unamortized debt issuance costs of 3,350 and 3,832 at june 30,2020 and december 31, 2019, respectively                    415,850,000                  
  notes payable, net of unamortized debt issuance costs of 668 and 667 at june 30,2020 and december 31, 2019, respectively                    50,610,000                  
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2020 and december 31, 2019, respectively                    74,959,000                  
  total global medical reit inc. stockholders’ equity                    427,921,000     340,220,000             
  credit facility, net of unamortized debt issuance costs of 3,607 and 3,832 at march 31, 2020 and december 31, 2019, respectively                     425,843,000                 
  notes payable, net of unamortized debt issuance costs of 634 and 667 at march 31, 2020 and december 31, 2019, respectively                     38,648,000                 
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2020 and december 31, 2019, respectively                     74,959,000                 
  credit facility, net of unamortized debt issuance costs of 3,832 and 3,922 at december 31, 2019 and 2018, respectively                      347,518,000                
  notes payable, net of unamortized debt issuance costs of 667 and 799 at december 31, 2019 and 2018, respectively                      38,650,000                
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2019 and 2018, respectively                      74,959,000                
  credit facility, net of unamortized discount of 3,983 and 3,922 at september 30, 2019 and december 31, 2018, respectively                       363,242,000               
  notes payable, net of unamortized discount of 701 and 799 at september 30, 2019 and december 31, 2018, respectively                       38,651,000               
  due to related parties                       1,584,000 1,358,000 1,100,000 1,030,000 1,028,000 987,000 1,035,000 1,036,000 802,286 638,790 586,899 580,911 1,135,302 2,493,401 1,068,562 
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2019 and december 31, 2018, respectively                       74,959,000               
  credit facility, net of unamortized discount of 3,784 and 3,922 at june 30, 2019 and december 31, 2018, respectively                        315,691,000              
  notes payable, net of unamortized discount of 733 and 799 at june 30, 2019 and december 31, 2018, respectively                        38,652,000              
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2019 and december 31, 2018, respectively                        74,959,000              
  liabilities and stockholders’ equity                                      
  credit facility, net of unamortized discount of 3,682 and 3,922 at march 31, 2019 and december 31, 2018, respectively                         219,993,000             
  notes payable, net of unamortized discount of 766 and 799 at march 31, 2019 and december 31, 2018, respectively                         38,652,000             
  stockholders’ equity:                                      
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2019 and december 31, 2018, respectively                         74,959,000             
  total stockholders’ equity                         370,562,000 299,750,000 254,656,000 255,513,000 254,743,000         
  total liabilities and stockholders’ equity                         656,690,000             
  revolving credit facility, net of unamortized discount of 3,922 and 2,750 at december 31, 2018 and 2017, respectively                          276,353,000            
  notes payable, net of unamortized discount of 799 and 930 at december 31, 2018 and 2017, respectively                          38,654,000            
  stockholders' equity:                                      
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at december 31, 2018 and 2017, respectively                          74,959,000            
  total liabilities and stockholders' equity                          636,099,000 604,091,000 602,027,000 539,856,000 474,571,000 428,927,663 369,395,591 325,768,465 227,319,130 205,791,478 98,385,696 96,096,760 
  revolving credit facility, net of unamortized discount of 4,127 and 2,750 at september 30, 2018 and december 31, 2017, respectively                           293,273,000           
  notes payable, net of unamortized discount of 832 and 930 at september 30, 2018 and december 31, 2017, respectively                           38,643,000           
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at september 30, 2018 and december 31, 2017                           74,959,000           
  deferred financing costs                            2,955,000 3,105,000 2,750,000 2,977,981 2,770,144 1,570,381 927,085    
  revolving credit facility                            288,350,000 229,150,000 164,900,000 126,100,000 144,500,000 128,900,000 27,700,000    
  notes payable, net of unamortized discount of 865 and 930 at june 30, 2018 and december 31, 2017, respectively                            38,610,000          
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at june 30, 2018 and december 31, 2017                            74,959,000          
  notes payable, net of unamortized discount of 898 and 930 at march 31, 2018 and december 31, 2017, respectively                             38,577,000         
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 issued and outstanding at march 31, 2018 and december 31, 2017                             74,959,000         
  notes payable, net of unamortized discount of 930 and 1,062 at december 31, 2017 and 2016, respectively                              38,545,000        
  notes payable to related parties                                 421,000 421,000 421,000   
  preferred stock, 0.001 par value, 10,000 shares authorized; 3,105 and no shares issued and outstanding at december 31, 2017 and 2016, respectively                              74,959,000        
  cash                               6,776,501 12,033,797 8,356,599 19,671,131 81,347,992 2,574,804 507,281 
  notes payable, net of unamortized discount of 963,184 and 1,061,602 at september 30, 2017 and december 31, 2016, respectively                               38,511,716       
  preferred stock, 0.001 par value, 10,000,000 shares authorized; 3,105,000 and no shares issued and outstanding at september 30, 2017 and december 31, 2016, respectively                               74,959,003       
  less: accumulated depreciation                                -6,520,555 -4,669,968 -3,323,915 -2,517,532 -1,932,083 -1,388,081 
  notes payable, net of unamortized discount of 995,990 and 1,061,602 at june 30, 2017 and december 31, 2016, respectively                                38,478,910      
  preferred stock, 0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding                                      
  common stock 0.001 par value, 500,000,000 shares authorized at june 30, 2017 and december 31, 2016, respectively; 21,105,675 and 17,605,675 shares issued and outstanding at june 30, 2017 and december 31, 2016, respectively                                21,106      
  total stockholders' equity                                176,302,594 149,254,869 155,028,378 159,708,292 12,134,927 12,750,677 
  notes payable, net of unamortized discount of 1,028,797 and 1,061,602 at march 31, 2017 and december 31, 2016, respectively                                 38,446,103     
  common stock 0.001 par value, 500,000,000 shares authorized at march 31, 2017 and december 31, 2016, respectively; 17,605,675 shares issued and outstanding at march 31, 2017 and december 31, 2016, respectively                                 17,606     
  convertible debenture, due to related party                                      
  notes payable, net of unamortized discount of 1,061,602 and 302,892 at december 31, 2016 and december 31, 2015, respectively                                  38,413,298    
  stockholders' equity                                      
  common stock 0.001 par value, 500,000,000 shares authorized at december 31, 2016 and december 31, 2015, respectively; 17,605,675 and 250,000 shares issued and outstanding at december 31, 2016 and december 31, 2015, respectively                                  17,606    
  building and improvements                                   113,094,766 87,040,410 87,040,410 
  accrued expenses                                   416,230 3,078,078 1,568,004 
  notes payable, net of unamortized discount of 1,177,522 and 302,892 at september 30, 2016 and december 31, 2015, respectively                                   39,920,275   
  common stock 0.001 par value, 500,000,000 shares authorized at september 30, 2016 and december 31, 2015, respectively; 17,605,675 and 250,000 shares issued and outstanding at september 30, 2016 and december 31, 2015, respectively                                   17,606   
  convertible debenture, due to majority stockholder                                    25,030,134 25,030,134 
  note payable to majority stockholder                                    421,000 421,000 
  note payable to related party                                    450,000 450,000 
  notes payable, net of unamortized discount of 1,240,126 and 302,892 at june 30, 2016 and december 31, 2015, respectively                                    54,458,657  
  common stock 0.001 par value, 500,000,000 shares authorized at june 30, 2016 and december 31, 2015, respectively; 1,426,656 and 250,000 shares issued and outstanding at june 30, 2016 and december 31, 2015, respectively                                    1,427  
  prepaid assets                                     27,925 
  notes payable, net of unamortized discount of 1,302,730 and 302,892, respectively                                     54,488,884 
  preferred stock, 0.001 par value, 100,000,000 shares authorized; no shares issued and outstanding                                      
  common stock 0.001 par value, 500,000,000 shares authorized at march 31, 2016 and december 31, 2015, respectively; 1,426,656 and 250,000 shares issued and outstanding at march 31, 2016 and december 31, 2015, respectively                                     1,427 

We provide you with 20 years of balance sheets for Global Medical REIT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Global Medical REIT. Explore the full financial landscape of Global Medical REIT stock with our expertly curated balance sheets.

The information provided in this report about Global Medical REIT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.